Skip to main content

Claro Advisors LLC

SEC CIK
0001764386
Latest filing
Jul 30, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Claro Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
3,407
Value
$266.7K
% of portfolio
<0.1%
Quarters held
2
Since Q1 2026
Holdings of HALO by Claro Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,407$266.7K<0.1%−165−4.6%ReducedHolders
Q1 20263,572$230.9K<0.1%+3,572NewHolders